Skip to main content
. 2022 Oct 31;11(21):6483. doi: 10.3390/jcm11216483

Table 3.

The absolute risk and attributable proportion of different HPV types by pathology.

HPV Type Negative CIN1 Relative Risk CIN2+ Relative Risk
Absolute Risk (%) Attributable Fraction (%) Absolute Risk (%) Attributable Fraction (%) Absolute Risk (%) Attributable Fraction (%)
HPV6 0.8 (0.6–1.0) 0.6 (0.4–0.8) 3.1 (1.1–8.7) 1.3 (0.3–6.1) 2.2 0.8 (0.1–4.2) 0 2.2
HPV11 0.3 (0.2–0.4) 0.1 (0.1–0.3) 0.0 0 0 0.8 (0.1–4.2) 0 0
HPV16 2.8 (2.4–3.3) 2.6 (2.2–3.0) 20.8 (14.0–24.0) 17.4 (11.2–26.1) 6.7 57.6 (40.1–65.7) 56.2 (47.7–64.4) 21.6
HPV18 1.1 (0.9–1.4) 0.8 (0.6–1.1) 8.3 (4.3–15.5) 4.6 (1.9–10.7) 5.8 6.1 (3.1–11.5) 4.3 (1.9–9.2) 5.4
HPV31 1.2 (0.9–1.5) 0.9 (0.7–1.2) 6.3 (2.9–12.9) 2.3 (0.7–7.6) 2.6 1.5 (0.4–5.4) 1.1 (0.3–4.8) 1.2
HPV33 0.6 (0.4–0.8) 0.5 (0.3–0.7) 7.3 (3.6–14.2) 5.2 (2.3–11.5) 10.4 3.8 (1.6–8.6) 2.2 (0.7–6.3) 4.4
HPV35 0.6 (0.4–0.8) 0.4 (0.2–0.6) 3.1 (1.1–8.7) 1.2 (0.2–5.8) 3.0 4.6 (2.1–9.6) 0 0
HPV39 1.2 (0.9–1.5) 0.9 (0.7–1.2) 1.0 (0.2–5.6) 0 0 3.0 (1.2–7.5) 0 0
HPV45 0.4 (0.2–0.6) 0.3 (0.2–0.5) 2.1 (0.6–7.2) 0 0 0.8 (0.1–4.2) 0.8 (0.1–4.2) 2.7
HPV51 1.8 (1.5–2.1) 1.3 (1.1–1.7) 7.3 (3.6–14.2) 4.3 (1.7–10.3) 3.3 6.1 (3.1–11.5) 2.9 (1.1–7.4) 2.2
HPV52 3.4 (3.0–3.9) 3.3 (2.8–3.7) 16.7 (10.6–25.3) 13.1 (7.8–21.2) 4.0 14.4 (9.4–21.4) 8.5 (4.8–14.5) 2.6
HPV56 1.3 (1.0–1.6) 0.9 (0.7–1.2) 6.3 (2.9–12.9) 0 0 3.0 (1.2–7.5) 0 0
HPV58 1.5 (1.2–1.8) 1.1 (0.9–1.4) 21.9 (14.8–31.0) 19.4 (12.8–28.3) 17.6 12.1 (7.6–18.8) 12.0 (7.5–19.0) 10.9
HPV59 0.7 (0.5–0.9) 0.5 (0.3–0.7) 2.1 (0.6–7.2) 0 0 0.8 (0.1–4.2) 0 0
HPV66 1.5 (1.2–1.8) 1.0 (0.8–1.3) 3.1 (1.1–8.7) 3.1 (1.1–8.6) 3.1 3.8 (1.6–8.6) 1.2 (0.3–4.9) 1.2
HPV68 1.1 (0.9–1.4) 0.8 (0.6–1.1) 2.1 (0.6–7.2) 0 0 1.5 (0.4–5.7) 0 0

Note: The figures in the brackets represent 95% confidence interval; cervical intraepithelial neoplasia grade 1 (CIN1); cervical intraepithelial neoplasia grade 2 or above (CIN2+).